“Methadone Use in Pregnancy and It's Effects on Baby” - PowerPoint PPT Presentation

1 / 30
About This Presentation
Title:

“Methadone Use in Pregnancy and It's Effects on Baby”

Description:

Presentation Layout Template ... Evelyn Fulmore, Pharm.D. Supervisor, Pediatric Pharmacy Services McLeod Regional Medical Center – PowerPoint PPT presentation

Number of Views:73
Avg rating:3.0/5.0
Slides: 31
Provided by: ncperinata
Category:

less

Transcript and Presenter's Notes

Title: “Methadone Use in Pregnancy and It's Effects on Baby”


1
Methadone Use in Pregnancy and It's Effects on
Baby
  • Evelyn Fulmore, Pharm.D.
  • Supervisor, Pediatric Pharmacy Services
  • McLeod Regional Medical Center
  • Florence, SC

2
Objectives
  • Overview of Opiate Addiction in pregnancy
  • Describe the use of methadone in opiate-dependent
    pregnant patient
  • Discuss the effects of maternal methadone use on
    the newborn
  • Review current treatment strategies for opiate
    abstinence syndrome in the newborn

3
Statistics on Substance Abusein Pregnancy
  • 4 percent of pregnant women use illicit drugs
    such as marijuana, cocaine, Ecstasy and other
    amphetamines, and heroin
  • 50 of all babies of heroin users are born with
    low birth weight
  • Babies exposed to heroin have increase risk of
    SIDS
  • Stopping heroin abruptly during pregnancy may
    increase risk of death of the baby

4
Statistics on Substance AbuseDemographics
5
Overview of Addiction (Opioids)
  • Naturally occurring opioids Endorphins
  • Endorphins aka the morphine within
  • Function identical to heroin or morphine
  • Provide pain control, learning, regulating body
    temp, etc.
  • Addiction assoc with use of opioids connected to
    chemical imbalance and damage

6
Medications Used to Treat Opiate Addiction
  • Methadone (Dolophine, Methadose, Methadose oral
    concentrate)
  • Given orally
  • Used throughout pregnancy
  • Neonatal Abstinence Syndrome (NAS)
  • Buprenorphine (Subutex, Suboxone)
  • Given sublingually
  • Limited studies in treatment of NAS

7
Types of Opioid or Opiate Drugs
  • Derived fully or partially from Opium
  • Heroin
    Morphine
  • Codeine Fentanyl
  • Hydromorphone Meperidine
  • Oxycodone Propoxyphene
  • Hydrocodone Buprenorphine
  • Methadone
  • Pentazocine

8
Structural CharacteristicsOpiates vs. Heroin
heroin
morphine
methadone
codeine
9
Methadone
  • C-II narcotic (opioid) µ receptor agonist
  • a substitute for opiate drugs of abuse heroin
  • produces similar effects and reduces withdrawal
    symptoms

methadone
heroin
10
Methadone
  • 40 mg dispersible tab - must be dissolved in
    water/juice
  • 5 and 10 mg regular tablets
  • 1 mg/ml or 10 mg/ml concentrate note
    concentrate must be mixed in water/juice

40 mg tab
5 and 10 mg tablets
10 mg/ml oral conc
1 mg/ml oral soln
11
MethadoneTreatment of Opioid Abuse
  • Goal of maintenance therapy
  • Does not create euphoria, sedation, or analgesia
  • Endpoint cravings stop
  • Establish individualized dosing
  • Usually require 60 to 120 mg/day

12
MethadoneSide effects
  • Long t-1/2 may result in overdose
  • Potential for apnea, respiratory failure,
    seizures
  • Be aware of multiple drugs that can potentiate
    effects
  • Important Noncardiogenic pulmonary edema has
    resulted from therapeutic doses
  • Other sweating, constipation, weight gain,
    urinary retention

13
MethadoneDrug Interactions
  • May increase or decrease effectiveness
  • Rifampin, phenytoin, carbamazepine, HIV meds
  • Amitriptyline, ketaconazole, fluvoxamine
  • Drugs to avoid block effects of Methadone
  • Pentazocine (Talwin)
  • Naltrexone (Revia)
  • Tramadol (Ultram)

14
Methadone Effects on Pregnancy
  • Widely studied
  • Treatment of choice
  • Not harmful to the developing fetus
  • May prevent miscarriage, fetal distress, or
    premature labor

15
Methadone Effects on Pregnancy
  • Decrease dose in the 1st trimester increases
    risk for miscarriage
  • Metabolism changes during pregnancy
  • Once daily
  • Split dosing

16
MethadoneEffects on Baby
  • Does not cause fetal abnormalities
  • Not associated with premature and LBW
  • Infant can be weaned (if needed)
  • Breastfeeding is safe

17
Methadone Maintenance tx in Pregnancy
  • Do better if treated with methadone
  • Longer gestational periods
  • Higher birth weights
  • Lower risk of exposure to HIV
  • Neonates/premature infants born to women
    dependent to methadone at risk for neonatal
    abstinence syndrome (NAS)

18
Buprenorphine(Suboxone/Subutex)
  • FDA approved
  • Treatment of opioid addiction
  • Relieves withdrawal, reduces cravings, and blocks
    the effects of heroin and other opiates
  • Maintenance doses 12 to 32 mg/day (sublingually)
  • Doses must be individualized (like Methadone)
  • Suboxone contains naloxone (hard to overdose)

19
Buprenorphine(Suboxone/Subutex)
  • Prescribers must be trained
  • Internet or one day course
  • A directory of prescribers can be found at
  • http//buprenorphine.samhsa.gov/bwns_locator
  • Doses must be individualized (like Methadone)

20
Neonatal Abstinence Syndrome (NAS) - Definition
  • NAS is a complex of signs and symptoms in the
    postnatal period associated with the sudden
    withdrawal of maternally transferred opioid

21
Neonatal Abstinence Syndrome (NAS)
  • 60-90 of infants born to substance abusing
    mothers will develop signs and symptoms of NAS
  • 50-75 will require treatment
  • The onset of withdrawal is 48 to 72 hours after
    delivery
  • Larger doses of methadone in late pregnancy
    associated with greater risk for withdrawal
  • Weaning of methadone in late pregnancy (?)

22
Neonatal Abstinence Syndrome (NAS) - Assessment
Scales
  • Lipsitz tool (1975)
  • Finnegan method
  • Ostrea system
  • Modified Finnegan Scoring System

23
Neonatal Abstinence Syndrome (NAS) - Diagnosis
  • A maternal history of substance abuse during
    pregnancy often forms the basis for diagnosis of
    NAS
  • AAP recommends the use of an objective abstinence
    scoring method to measure the severity of
    withdrawal
  • APP favors the Lipsitz method for NAS scoring

24
Neonatal Abstinence Syndrome (NAS) Clinical
Features
  • Autonomic Signs
  • Increased sweating
  • Nasal stuffiness
  • Fever
  • Mottling
  • Temp instability
  • Gastrointestinal Dysfunction
  • Poor feeding
  • Uncoordinated and constant sucking
  • Vomiting
  • Diarrhea
  • Dehydration
  • Poor weight gain

25
Neonatal Abstinence Syndrome (NAS) Clinical
Features
  • Neurologic excitability
  • Tremors
  • Irritability
  • Increased wakefulness
  • High-pitched crying
  • Increased muscle tone
  • Hyperactive deep tendon reflexes
  • Exaggerated Moro reflex
  • Seizures
  • Frequent yawning and sneezing

26
NAS Treatment Strategies
  • Tincture of Opium/Paregoric
  • Morphine
  • Methadone
  • Other
  • Buprenorphine
  • Clonidine
  • Phenobarbital
  • Diazepam

27
NAS Treatment StrategiesTO Dosing
  • Tincture of Opium TO (10 mg/ml)
  • Start at 0.1 ml/kg or 2 drops/kg with feedings
    every four hours
  • Increased by 2 drops/kg every 2 hours as needed
  • After symptoms stabilize over 3 to 5 days, begin
    taper
  • 25 fold dilution of TO is the morphine
    equivalent to Paregoric 0.4 mg/ml

28
NAS Treatment StrategiesMethadone Dosing
  • Methadone
  • 0.05 to 0.1 mg/kg every 6 hours with increase of
    0.05 mg/kg until signs controlled. After signs
    controlled give dose every 12 to 24 hours (AAP,
    1998)
  • 0.05 to 0.2 mg/kg every 12 to 24 hours (Neofax)
  • 0.5 mg/kg/day divided every 8 hours (Lexicomp)
  • Tapering
  • Decrease dose by 10 to 20 per week over 1 to
    1-1/2 months

29
Conclusion
  • Maternal use of methadone will continue to
    increase as prescription opioids and illicit
    drugs are used
  • Larger maternal doses of methadone may result in
    delayed withdrawal in the infant
  • Implementing a hospital specific NAS policy is
    recommended
  • Evaluate the effectiveness of your NAS policy
  • Training and education of all disciplines

30
Questions ?
Write a Comment
User Comments (0)
About PowerShow.com